1. Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infection. (1st November 2022) Authors: Hu, Yanbin; Sun, Fei; Yuan, Qiang; Du, Jinhua; Hu, Lihong; Gu, Zhengxian; Zhou, Qiong; Du, Xiaoting; He, Shibo; Sun, Ya; Wang, Qian; Fan, Lirong; Wang, Lina; Qin, Shaohua; Chen, Shuhui; Li, Jian; Wu, Wenqiang; Mao, John; Zhou, Yixin; Zhou, Qiaoyun Journal: Bioorganic & medicinal chemistry letters Issue: Volume 75(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗